47
Views
3
CrossRef citations to date
0
Altmetric
Practice Pearl

Review of the Safety and Efficacy of Linagliptin as Add-On Therapy to Metformin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study

, MD & , MD
Pages 183-186 | Published online: 13 Mar 2015
 

Practice Pearl

This trial in patients with type 2 diabetes inadequately controlled on metformin demonstrated the efficacy of adding linagliptin 5 mg once daily; this novel dipeptidyl peptidase-4 inhibitor significantly improved glycemic control without weight gain or increased risk of hypoglycemia.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.